Lucid Pharma LLC recalls Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b
Recalled June 28, 2017 · FDA recall D-0921-2017 · Lucid Pharma
Hazard
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules. · FDA Class II
Units
a) 44168 bottles; b) 24960 bottles
Sold at
Nationwide in the USA
Description
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Product
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Manufacturer(s)
Lucid Pharma LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →